CGEN-54

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCGEN-54
Drug Alias NameMCP1/CCR2 antagonist (Compugen/Teva)CGEN-54
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-C chemokine receptor type 2 antagonistsC-C motif chemokine 2 inhibitors
TargetsC-C motif chemokine 2C-C chemokine receptor type 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Pharmaceutical Industries LtdCompugen Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A